Edwards Lifesciences

Medical Equipment
EW
$ 72 (1.5)%
Share price
$ 44 bn
Market Cap
$ 44 bn
Enterprise Value

Carbon footprint

1.1 Ton
GHG emissions per $ 1 mln investment
0.03x the weighted average for S&P 500
FY2021
How is this calculated?
-0.7%
YOY change in GHG emissions
Weaker than the -0.8% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

but has a science based goal that does not target absolute reductions but is still aligned with Paris Agreement according to SBTi

GHG emissions and Carbon intensity

Edwards Lifesciences's GHG emissions (market-based) (Kt of CO2e)
Edwards Lifesciences's Carbon intensity (Tons per 1 USDm)

Edwards Lifesciences's carbon footprint

Edwards Lifesciences reported gross GHG emissions (Scope 1 + 2 before carbon offsets) for the twelve months ending 31 December 2021 at 46 Kt (-0.34 /-0.7% y-o-y). Also positively, carbon intensity plunged to 8.8 t (-1.7 /-16.2% y-o-y).

Edwards Lifesciences reported Scope 3 emissions for the the twelve months ending31 December 2021 at 417

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Edwards Lifesciences also has a science-based goal that, however, does not appear to explicitly target a company-wide reduction in emissions in absolute terms. Edwards Lifesciences commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year. Edwards Lifesciences also commits to reduce scope 3 GHG emissions 51.6% per USD of value added within the same timeframe.

Company environmental metrics

Show more...